A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors

This study has been completed.

Study NCT00046111 Information provided by GlaxoSmithKline

First Received: September 19, 2002 Last Updated: March 6, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given